Recombinant Ralstonia eutropha for PHBHHx Yield and Monomer Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing polyhydroxybutyrate-co-3-hydroxyhexanoate (PHBHHx) in Ralstonia eutropha are inefficient and lack control over the molar ratio of 3-hydroxycaproic acid monomer, necessitating a novel microorganism for enhanced synthesis.
Innovation Solution
A recombinant Ralstonia eutropha strain is engineered by introducing a phaJ4b promoter and a phaC mutant gene, with the phaC gene either being knocked out or present on a stable plasmid, to increase the proportion of 3-hydroxycaproic acid in PHBHHx production.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If a promoter for upregulating phaJ4b gene is introduced and phaC mutant gene is expressed, then the proportion of 3-hydroxycaproic acid in PHBHHx is increased, but the device complexity and genetic engineering complexity increase
Solution Approach 1:
The patent divides the genetic modification into separate modules: introducing a promoter for phaJ4b gene upregulation and introducing a phaC mutant gene are performed as distinct genetic engineering steps. This segmentation allows independent optimization and control of each modification's effect on PHBHHx composition.
Solution Approach 2:
The patent changes genetic parameters (promoter strength, gene sequence) to achieve desired product composition. By upregulating phaJ4b expression through promoter introduction and modifying phaC gene sequence, the molar ratio of 3-hydroxycaproic acid monomer in PHBHHx is precisely controlled.
2Manufacturing precision
If phaC gene is knocked out or placed on stable plasmid, then the synthesis of PHBHHx with controlled monomer ratio is achieved, but the reliability and stability of gene expression may be affected
Solution Approach 1:
The patent uses a stable plasmid as an intermediary carrier to introduce and maintain the phaC mutant gene. The plasmid acts as a mediator between the host genome and the modified gene, allowing controlled expression while maintaining genetic stability through plasmid maintenance mechanisms.
Solution Approach 2:
Instead of modifying the native phaC gene in the genome, the patent inverts the approach by knocking out the original phaC gene and introducing a mutant version on a plasmid. This inversion allows precise control over gene expression and composition while avoiding potential instability from genomic modifications.
3Productivity
If existing methods are used for PHBHHx production, then the process is simpler, but the yield is insufficient and fermentation performance is poor
Solution Approach 1:
The patent performs preliminary genetic engineering modifications (introducing promoter, introducing phaC mutant gene) before fermentation to create an optimized strain. This preliminary action ensures high PHA yield potential is built into the strain genetics, which then translates to improved fermentation performance and productivity.
Data Source
Figure 1
AI summary
The present invention relates to a recombinant bacterium with a high PHA yield and the construction method thereof, providing an engineered microorganism that can be used for the production of polyhydroxyalkanoate (PHA), and more particularly, to a recombinant Ralstonia eutropha with a high PHA yield, wherein the recombinant Ralstonia eutropha comprises a promoter for upregulating a phaJ gene and further comprises a mutant phaC gene. The recombinant Ralstonia eutropha provided by the present invention can be used for producing 3-hydroxybutyrate-co-3-hydroxyhexanoate (PHBHHx) in PHA.